Justera Health Ltd.
VTAL
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -219.30% | 96.55% | 86.55% | 73.44% | 47.08% |
| Total Depreciation and Amortization | -74.31% | -70.60% | -70.18% | 116.74% | -9.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -109.67% | -- |
| Total Other Non-Cash Items | 2,678.86% | -942.86% | -273.22% | -163.29% | 2,242.86% |
| Change in Net Operating Assets | 141.22% | -99.25% | -75.21% | 123.25% | -50.34% |
| Cash from Operations | 1,778.69% | 90.90% | 62.69% | 51.90% | 167.97% |
| Capital Expenditure | -- | -- | -- | -254.90% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -336.19% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 48.00% | 21.78% | -15.77% | -70.33% | -47.06% |
| Issuance of Common Stock | -- | -- | -- | 11.39% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -5,150.00% | -- |
| Cash from Financing | 48.81% | 23.35% | -16.46% | 1.90% | -43.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -110.53% | 100.26% | 68.53% | -7.17% | 115.97% |
